96 related articles for article (PubMed ID: 9480160)
1. [Lymphocyte interactions in platelet concentrates from buffy coats. Determination of proliferating cells using Ki-67 antibodies].
Müller-Steinhardt M; Klüter H; Kirchner H
Beitr Infusionsther Transfusionsmed; 1994; 32():66-8. PubMed ID: 9480160
[TBL] [Abstract][Full Text] [Related]
2. [Differentiation of leukocytes in thrombocyte concentrates by APAAP staining].
Müller-Steinhardt M; Klüter H; Kirchner H
Beitr Infusionsther; 1992; 30():127-30. PubMed ID: 1284687
[TBL] [Abstract][Full Text] [Related]
3. [Effect of leukocyte contamination on storage of platelet concentrates from buffy coats].
Klüter H; Klinger M; Bauhaus M; Kirchner H
Beitr Infusionsther Transfusionsmed; 1994; 32():61-5. PubMed ID: 9480159
[TBL] [Abstract][Full Text] [Related]
4. Filter Buffy Coats (FBC): a source of peripheral blood leukocytes recovered from leukocyte depletion filters.
Meyer TP; Zehnter I; Hofmann B; Zaisserer J; Burkhart J; Rapp S; Weinauer F; Schmitz J; Illert WE
J Immunol Methods; 2005 Dec; 307(1-2):150-66. PubMed ID: 16325197
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of thrombocyte concentrates from buffy coats after 3 and 16 hours of storage].
Häberle H; Schulzki T; Kretschmer V
Beitr Infusionsther Transfusionsmed; 1994; 32():73-7. PubMed ID: 9480161
[TBL] [Abstract][Full Text] [Related]
6. The preparation of platelet concentrates by the light-spin/hard-spin technique.
Dzik WH
Transfus Sci; 1991; 12(3):171-81. PubMed ID: 10149546
[TBL] [Abstract][Full Text] [Related]
7. [Relationship of state of aggregation with various biochemical parameters--tested on platelet concentrates from buffy coats after 5 days of storage].
Posch U; Kokelj M; Kostner GM; Lanzer G
Beitr Infusionsther Transfusionsmed; 1994; 32():78-80. PubMed ID: 9480162
[TBL] [Abstract][Full Text] [Related]
8. Elimination and multiplication of bacteria during preparation and storage of buffy coat-derived platelet concentrates.
Mohr H; Bayer A; Gravemann U; Müller TH
Transfusion; 2006 Jun; 46(6):949-55. PubMed ID: 16734811
[TBL] [Abstract][Full Text] [Related]
9. [Preparation of leukocyte-reduced platelet concentrates from buffy coats using a novel separation apparatus].
Müller N; Krüssel H
Beitr Infusionsther Transfusionsmed; 1994; 32():52-4. PubMed ID: 9480156
[TBL] [Abstract][Full Text] [Related]
10. Stability of antigens on leukocytes in banked platelet concentrates: decline in HLA-DR antigen expression and mixed lymphocyte culture stimulating capacity following storage.
Sherman ME; Dzik WH
Blood; 1988 Sep; 72(3):867-72. PubMed ID: 2970874
[TBL] [Abstract][Full Text] [Related]
11. Automated preparation of platelet concentrates from pooled buffy coats using the Gambro OrbiSac system.
Gulliksson H; Sjödin A; Sandgren P; Vesterinen M; Larsson S; Diedrich B
Transfus Apher Sci; 2003 Aug; 29(1):11-2. PubMed ID: 12877886
[No Abstract] [Full Text] [Related]
12. Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates.
Edvardsen L; Taaning E; Dreier B; Christensen LD; Mynster T; Nielsen HJ
Am J Hematol; 2001 Jul; 67(3):157-62. PubMed ID: 11391711
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric determination of leukocytes and lymphocyte subsets in thrombocytapheresis products.
Garritsen HS; Sibrowski W
Beitr Infusionsther Transfusionsmed; 1994; 32():401-4. PubMed ID: 9422120
[TBL] [Abstract][Full Text] [Related]
14. Cytokines in platelet concentrates prepared from pooled buffy coats.
Klüter H; Müller-Steinhardt M; Danzer S; Wilhelm D; Kirchner H
Vox Sang; 1995; 69(1):38-43. PubMed ID: 7483490
[TBL] [Abstract][Full Text] [Related]
15. Quality of platelet concentrates derived by platelet rich plasma, buffy coat and Apheresis.
Vasconcelos E; Figueiredo AC; Seghatchian J
Transfus Apher Sci; 2003 Aug; 29(1):13-6. PubMed ID: 12877887
[TBL] [Abstract][Full Text] [Related]
16. [Platelet-leukocyte aggregates as a marker for platelet activation in platelet concentrates].
Chakroun T; Abdelkefi S; Bouslama M; Houissa B; Zaier M; Miled A; Kortas M; Yacoub S
Transfus Clin Biol; 2008 Sep; 15(4):148-53. PubMed ID: 18760949
[TBL] [Abstract][Full Text] [Related]
17. Platelet storage lesion: an update on the impact of various leukoreduction processes on the biological response modifiers.
Seghatchian J
Transfus Apher Sci; 2006 Feb; 34(1):125-30. PubMed ID: 16376152
[TBL] [Abstract][Full Text] [Related]
18. Expression of activation antigens on lymphocyte surface and circulating platelet-leukocyte aggregates in ischaemic heart disease.
Czyz A; Kołacz E; Angerer D; Zawilska K
Kardiol Pol; 2005 Mar; 62(3):189-200; discussion 201. PubMed ID: 15830013
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of transfusion of prestorage-leukoreduced apheresis platelets.
Ogawa Y; Wakana M; Tanaka K; Oka K; Aso H; Hayashi M; Seno T; Ishida T; Nomura S; Fukuhara S
Vox Sang; 1998; 75(2):103-9. PubMed ID: 9784662
[TBL] [Abstract][Full Text] [Related]
20. Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy.
Akkök CA; Brinch L; Lauritzsen GF; Solheim BG; Kjeldsen-Kragh J
Vox Sang; 2007 Jul; 93(1):42-8. PubMed ID: 17547564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
